A nuclear protein that recognizes UV-damaged DNA was detected from HeLa cells using DNA-binding assay. Treatment of cells with Ca 2+ ionophore (A23187) caused a dramatic inhibition of the damagerecognition activity. In contrast, in vitro treatment of nuclear extracts with agents that affect protein conformation (such as urea, NP40 and Ca 2+ ) did not significantly affect on the damage-recognition activity. The Ca 2 + -mediated inhibition of UV damage recognition was reconstituted by the addition of the cytosolic extracts, suggesting that the Ca 2+ effect does not directly act on the UV damage-recognition protein. The expression of the detected nuclear protein was increased in UV-resistant HeLa cells. In contrast, the level of this protein was dramatically reduced in UVsensitive xeroderma pigmentosum group A cells. In addition, UV damage-recognition protein is resistant to RNase, and is independent of the previously identified proteins that bind cisplatin-DNA adduct. These findings implied that the recognition of UV-DNA adduct is modulated by the intracellular level of Ca 2+ .
INTRODUCTION
Ultraviolet (UV) light causes a cyclobutane-type pyrimidine dimer as well as other DNA base adducts on cellular DNA, which are normally repaired in human cells through excision repair (1) . It has also been demonstrated that the removal of the major cisplatin adducts involves nucleotide excision repair in bacterial (2) (3) (4) and in mammalian cells (5) (6) . These results argued that the repair process of cisplatin-adduct is probably the same, at least in part, as that of 'UV-type' excision repair. This is supported by the observation of cross-resistance and enhanced plasmid reactivation of cisplatin-resistant HeLa cells to UV damage (7) (8) . In addition, it has been shown that nuclear extracts isolated from mammalian and yeast mutants in DNA repair fail to interact with damaged DNA (9-10). Since UVtype excision repair involves multiple steps which require different enzymes and accessory proteins that presumably must have access to the damaged DNA for effective repair to occur (1, 11) , it is reasonable to think that one or more of these factors can be identified through DNA-binding activity. To date, little is known about the damage recognition and its regulation in cells.
We have previously shown that a nuclear protein which binds to cisplatin adduct is overexpressed in a HeLa cell line resistant to cisplatin (12) . The same resistant cell line also showed cross resistance to UV (7) . In this study, we have identified a nuclear protein from HeLa cells using DNA-binding assay. This protein recognizes UV-modified DNA and its activity is modulated by Ca 2+ ionophore A23187. The expression of this damagerecognition protein (DRP) is increased in cisplatin-resistant HeLa cells, and reduced in xeroderma pigmentosum cells. These data have important implication in that the modulation of DNA damage recognition in cells by Ca 2+ may play a role in DNA repair and subsequently affect cellular sensitivity or resistance to DNAdamaging agents.
UV-irradiation and platination of DNA
The fl30 DNA (see below) at a concentration of 100 /tg/ml was irradiated with UV germicidal lamps as previously described (14) . DNA was irradiated with a fluence rate 25 J/m 2 /s from a VL-100C UV irradiation unit (Vilbert Lourmat, France). The fluence rate was measured by a VLX-254 radiometer (Vilbert Lourmat, France). The fl03 DNA (see below) at a concentration of 100 /ig/ml (3xlO~4 M-nucleotide phosphate) was treated with cisplatin in 3 mM NaCl, and 1 mM sodium phosphate (pH 7.4) at 37°C for 18-24 h as previously described (12) . According to Ushay et al. (15) this treatment generated an estimated molar ratio of free cisplatin to nucleotide phosphate of Tf = 0.08. Following this typical treatment, r b , the molar ratio of bound cisplatin to nucleotide phosphate, is ~0.8xr f .
DNA probes
The DNA fragment fl30 was originally isolated from plasmid pSVT (16) by restriction v/ithSph l-Bgl I. This 130 bp fragment was ligated toSph I andSma I opened vector pBS(+) (Stratagene) at Sph I site, the 5' recessed Bgl I site of fl30 was then filled with Klenow DNA polymerase (New England Biolabs, Inc.), and ligated to the Sma I site of the vector. The Hind Ul-Eco RI fl30 fragment containing 17 bp dA/dT rich region is a potential target for UV modification. The DNA fragment fl03 with protruding ends was the 103 bp Stu l-Ava II fragment from pcD-a-globin (17) , filled with Klenow DNA polymerase, and attached to Eco RI and Xba I linkers, respectively, and cloned into pBS(+). The flO3 fragment containing the 14 bp dG.dC rich region is a potential target for cisplatin modification. Hind III andEco RI generated fl03 and fl30 fragments were 32 P[dCTP]-labeled (3 X 10 4 cpm/ng DNA) using Klenow DNA polymerase and purified in spin columns by standard methods (18) .
Cell extracts and gel mobility shift assay Nuclear and cytosolic extracts were prepared according to Dignam et al. (19) . The protein concentration was measured by the method of Bradford (20) and visualized by SDSpolyacrylamide gel electrophoresis (21) . Gel mobility shift assay was performed in buffer containing 12% glycerol-12 mM Hepes (pH7.9)-100 mM KC1-5 mM MgCl 2 -4 mM Tris.HCl-1 mM EDTA-1 mM dithiothreitol-300 /tg/ml BSA as previously described (22) . Briefly, the DNA probe (0.3 ng) was incubated with cell extracts in 15 /*1 at 30°C for 30 min. For some cases, cell extracts were treated with proteinase K or RNase before the binding reaction. The reaction mixtures were then subjected to a 4% polyacrylamide gel electrophoresis under low ionic strength (6.7 mM Tris.HCl, pH7.9-3.3 mM sodium acetate-1 mM EDTA) at 25 °C and 15 mA constant current. The resolved gels were dried and exposed to Kodak XAR-5 X-ray film at -70°C with an intensifying screen. The intensity of the shifted DNA bands was determined by scanning the X-ray film through a scanning densitometer (Hoefer GS 300).
contrast, only the free probe was detected in the extract-free reaction (lane 1, indicated with T). This DRP is not the same as that which recognizes cisplatin-damaged DNA (12) as judged by the gel mobility of the bound DNA. When cisplatin-damaged DNA (i.e., f 103-pt) was used as a probe, a binding activity indicated with 'B' was identified. At high concentration of nuclear extract, another bound form which migrates slower than 'B' and with about the same rate as the UV DRP was detected (lane 6-8). fl03-pt alone did not show any retarded band (lane 5). The slowly migrating protein complex is probably the dimer or oligomer of 'B', since the cisplatin DRP (i.e., 'B') of 10 /*g extract appeared to be the same as that detected from the 2 /tg extract (compare lanes 7 and 8). The data suggest that the level of UV DRP was not saturated by the level of damage induced by 1000 J/m 2 of UV. The data suggest that the detected UV DRP is different from cisplatin DRP. This was supported by competition assays, and the data are shown in 
RESULTS

Detection of a UV DRP in HeLa nuclear extracts
Under the standard DNA-binding conditions (including 2 ng of poly[dI-dC]) with the indicated amounts of HeLa nuclear extracts, a UV DRP was detected. As shown in Fig. 1 A, the labeled probe (fl30-UV) was bound by a nuclear factor or factors that increases with the level of extracts (lanes 2-4, indicated with 'b'). In did not significantly compete for the UV DRP (indicated with an arrowhead) compared with the one without competitor (lane 3). In contrast, increasing the concentration of UV-damaged DNA (i.e., fl30-UV) as a competitor effectively competed for UV DRP (lanes 7-9). Most of the UV DRP was competed by 30 ng of specific competitor (compare lanes 3 and 9). The control lanes are probe alone (lane 1) and unirradiated fl30 with nuclear extract (lane 2). It should be noted that the detected UV DRP did not bind single-stranded DNA, neither its binding activity was competed by single-stranded DNA (data not shown), suggesting that the binding is specific for duplex DNA.
To localize the DRP in cells, partially purified nulear (N) or cytosolic (C) extracts were used for the DNA-binding assay. As shown in Fig. 2 , most of the cisplatin DRP appeared in the nuclear fraction (lane 2, indicated with 'B'). However, cytosolic extract also had a lower amount of cisplatin DRP (lane 3) probably because of cross containmination of the extract. Similarly, most of the UV DRP was localized in the nuclear fraction (lane 6, indicated with 'b'). The cytosolic fraction also showed slight binding (lane 7). This UV DRP is extremely sensitive to protease K (lane 8), but is resistant to RNase (lane 9), suggesting that the UV DRP is a protein or protein complex. For control, undamaged fl30 incubated with nuclear or cytosolic extract is shown in lane 4 and lane 5, respectively.
Modulation of LTV DRP by agents that modify protein conformation
The UV DRP was assayed for its DNA binding activity in vitro under the conditions containing agents that modify protein conformation. Urea, Nonidet-P-40 (NP-40), and Ca 2+ were used because their chemical nature has been demonstrated to modify the conformation of hsp70, and subsequently modulate its binding activity to the consensus heat shock element (23) . In our hands, these agents were also able to affect the binding activity of a human nuclear factor to the promoter region of a glyceraldehyde-3-phosphate dehydrogenase gene (Chao, C.C.-K., unpublished data). The results of UV DRP assays are shown in Fig. 3A . Two /ig of nuclear extract was used in the binding reaction containing the indicated concentrations of urea, NP-40, or Ca 2+ . The quantitated densitometric data are shown in Table  1 . The results indicate that urea (lanes 4-6) and NP-40 (lanes 7-9) in the tested concentrations did not significantly affect UV DRP activity as compared to the modifier-free reaction (lane 3). Similarly, Ca 2+ concentration upto 10 mM did not affect UV DRP (lanes 10-12). In contrast, 100 mM of Ca 2+ lowered the binding activity of UV DRP by 82% (compare lanes 13 and 3). Control lanes are UV-damaged probe alone (lane 1) and undamaged DNA with nuclear extract (lane 2). Since 100 mM of Ca 2+ is at least 100-fold higher than physiologic concentration, the observed inhibition is probably not due specifically to Ca 2+ , but rather to the ionic effect in general. However, this speculation was not supported by in vivo study (see below). The nuclear extracts from HeLa cells which have been treated with Ca 2+ ionophore (A23187) were assayed for UV DRP, and the results are shown in Fig. 3B . The quantitated data are shown in Table 2 . Treatment of cells with A23187 (7 for 5 h inhibited the DRP activity by 52% compared to the (lanes 2-3) . Symbols are as in Fig. 1. The relative levels of binding activity (mean ± SD) were determined by scanning densitometry of the X-ray films of three experiments. 
r-
untreated cells (compare lanes 2 and 3). Prolonging the treatment (15 h) caused further inhibition by 65% (lane 4)
. These results raise a possibility that the in vitro study of Ca 2+ effect on UV DRP probably needs additional factors that are not available in the nuclear extracts. One way to test this idea is by adding the cytosolic extracts to the reaction to reconstitute the Ca 2+ effect. The results are shown in Fig. 4 . DNA-binding reactions were set up under a series of Ca 2+ concentration (0.1 -100 mM) without (Fig. 4, lanes 3-6) or with (lanes 7-10) cytosolic extract, or with cytosolic extract but without nuclear extract (lanes 11 -14) . It appeared that the addition of cytosolic extraction totally blocked the UV DRP activity. There was no UV DRP activity detected in the cytosolic fraction. The control lanes are probe alone (lane 1), and the standard binding reaction without adding Ca 2+ (lane 2). The results suggest that inhibition of UV DRP activity is mediated by the Ca 2+ cocentration in the cells, and this negative effector is present in the cytosol.
Overexpression of UV DRP in resistant cells
The sensitivity of resistant and parental HeLa cells to UV was analyzed using colorimetric MTT assays (see Experimental for details). Known repair-competent VA13 cells (VA) and repairdeficient XP complementation group A cells (XP) (13) were included as controls. A typical dose-response curve for cellular sensitivity to UV is shown in Fig. 5 . The D^, UV fluence causing 50% inhibition of cell growth, for each cell line is indicated. Resistant HeLa cells has a 2.3-fold resistance to UV. XP cells are 8-and 5-fold more sensitive to UV than VA and HeLa cells, respectively. Nuclear extracts from these cells were prepared for DNA-binding assays. Two /*g of nuclear extracts from these cells were used to detect the UV DRP using DNA probe irradiated with 0, 1000 or 3000 J/m 2 . As shown in Fig. 6 , the involves different protein or a dimer of the same protein. The association of UV DRP and the cellular sensitivity to UV suggests that the identified UV DRP may play a functional role in the sensitivity or resistance of cells to UV.
Similarity of UV DRP between sensitive and resistant cells
To further verify whether the identified UV DRP in the sensitive and resistant cell lines is the same, a competition experiment was carried out. As shown in Fig. 7A , with increasing amounts of competitors the competition became apparent. Very little competition effect, if any, was detected if the amount of competitor is less than 10-fold (i.e., 3 ng) for both sensitive parental (panel P, compare lanes 2-4) and resistant HeLa cells (panel R, compare lanes 7-9). For both cell lines (lanes 5 and 10) significant competition was seen when competitors were increased by 100-fold (i.e., 30 ng). All of the UV DRP from sensitive or resistant cells was competed off by a 1000-fold competitors (lanes 6 and 11). Binding reaction without nuclear extract is shown in lane 1 as a control. Therefore, the overexpression of the identified DRP in resistant cells is specific for UV damage. In our hands, there is a -15% deviation in routinely performed DNA-binding assay. Altogather the three independent experiments, the quantitated data of the X-ray films by densitometry are shown in Fig. 7B . The slopes of the two response patterns are nearly the same, suggesting that the detected UV DRP from the two cell lines is the same in terms of damage recognition. It should be noted that a 100-fold molarity of the competitor inhibited about 50% of the binding activity, implying that the chemical nature of DNA binding is different from the promoter-binding proteins such as those of human glucoseregulated protein gene promoter to which a near 100% inhibition is observed with the same molarity of sequence-specific competitor (Chao, C.C.-K. et al., unpublished data).
DISCUSSION
In this study, we have identified a cellular protein that recognizes UV-damaged DNA. The majority of this DRP is localized in the nucleus, and is probably conserved in human cells. than the sensitive parental cells. In contrast, XP cells showed significantly less UV DRP than resistant cells. It is known that XP cells are extremely sensitive to UV and chemical damages (1) . In addition, the resistant HeLa cells were originally selected for cisplatin resistance and revealed cross-resistance to some alkylating agents (13) . These findings may have an implication in that the identified protein is potentially important for the sensitivity or resistance of cells to DNA-damaging agents. We have previously shown that the resistant HeLa cells acquired 2-fold enhanced plasmid reactivation, accompanying a 2-fold increase in UV DRP (7) . These data may imply a correlation between UV DRP and DNA excision repair. Our preliminary data suggest that the repair synthesis rate and incision of damage in our resistant cells is the same as the sensitive parental cells (Chao, C.C.-K. et al., unpublished data), suggesting that damage recognition play a significant role for the enhanced DNA repair in this mutant cell line. Therefore, DRP may, through DNA repair, indirectly contribute to the sensitivity or resistance of cells to DNA damage. However, one should also recognize that when comparing these two different experiments where a small fragment is the target for UV (in plasmid reactivation) as compared to genomic DNA (in cytotoxicity assay) there is an enormous difference in target size.
Information gathered from this study is not enough to prove that the observed UV DRP is specific for UV-DNA adduct. As shown in Fig. 1A , at higher concentration of nuclear extracts, another bound form of cisplatin-damaged DNA become apparent and it has a similar mass size as the UV DRP complexed with DNA. This slowly migrating cisplatin DRP complex could be a dimer or oligomer form of 'B' (see Fig. 1A ). Alternatively, it could be the cisplatin-DNA adduct complexed by the UV DRP. We can not exclude the later possibility because it has been shown that changes in protein conformation can modulate the interaction between DNA-binding protein with consensus heat shock element (23) or glyceraldehyde-3-phosphate dehydrogenase gene promoter (C.C.-K. Chao et al., unpublished data). Therefore, modification of f 103 DNA fragment by cisplatin may result in a DNA domain suitable for the binding of UV DRP. This effect is especially apparent at high concentrations of nuclear extracts (compare lanes 6 -8 in Fig. 1A ). An apparent slowly-migrating form was detected when 10 fig nuclear extracts was used, while the level of the 'B' complex is the same as when 2 /tg was used (compare lanes 7 and 8 in Fig. 1A) . In contrast, UV-DNA adducts probably reveal a simplier conformation that is suitable for UV DRP but is not recognized by cisplatin DRP. The binding pattern of UV DRP was the same for UV fluence upto 9000 J/m 2 (data not shown). This may partly explain the failure in the detection of increased constitutive cisplatin DRP, but only increased UV DRP, in resistant HeLa cells (8, 12 ; S. Lippard, personal communication). Therefore, the identified UV DRP may not necessarily be UV specific as referring to the binding pattern of cisplatin DRP.
We have also demonstrated that the identified UV DRP is resistant to agents that modify protein conformation (i.e., urea and NP-40). More interestingly, treatment of cells with Ca 2+ ionophore resulted in a significant inhibition of UV DRP, suggesting that the binding activity of this DRP is modulated by the intracellular Ca 2+ . However, in vitro studies did not support this idea because there was no significant inhibition in the binding function of UV DRP with the addition of 10 mM of Ca 2+ . In addition, the physiologic level of Ca 2+ in the cell is at least 100-fold lower than the in vitro conditions, it is suggested that the inhibition of UV damage recognition is not due to the Ca 2+ concentration alone. This inhibition phenomenon could result directly from the Ca 2+ -dependent inactivation of UV DRP, or it could be mediated by Ca 2 " 1 "-associated cytosolic proteins. Since the in vitro data did not support the former hypothesis, the Ca 2+ effect on UV DRP is probably mediated by the latter pathway. In fact, we have recently found that pretreatment of cytosolic extract with proteinase K dramatically reduced the inhibition of the UV DRP activity (Chao, C.C.-K. et al., unpublished data). These findings suggest a multifactorial modulation of the function of UV DRP in cells including a Ca 2+ -mediated pathway. It has also recently been reported by others that a constitutive UV DRP can be induced by pretreatment of monkey cells with UV fluence (25) . Altogether, the level of constitutive DRPs is important but it may not necessarily correlate with the sensitivity or resistance of cells to DNA damaging agents. One should also consider the inducible level of DRPs in pondering the potential importance of cellular proteins to cytotoxicity. Therefore, the observed Ca 2+ -mediated modulation of UV DRP may be potentially relevant in cellular response to damaging agents.
